MAY 22, 2017 10:00 AM PDT

WEBINAR: The clinical impact and implementation of T2MR and the T2Candida Panel in the management of candidemia at a large tertiary care health system

Sponsored by: T2 Biosystems, Inc.
Speakers
  • Senior Staff Physician Director, Transplant Infectious Diseases , Medical Director of Infection Prevention, Henry Ford Hospital; Professor of Medicine, Wayne State University
    Biography
      Dr. Alangaden received his medical degree from the University of Bombay and has since completed post-graduate training in India, the United Kingdom and the United States. Dr. Alangaden is the Director of Transplant Infectious Diseases and Director of Infection Control and Prevention at Henry Ford Hospital and Transplant Institute.

      Dr. Alangaden's research interest lies in the epidemiology and outcomes of infections in immunocompromised patients and transplant recipients. He is also involved and well-published in the areas of research related to tuberculosis and nosocomial infections especially, Clostridium difficile.

    Abstract:

    DATE: May 22, 2017
    TIME: 10:00am PT, 1:00pm ET

    Learn from renowned clinical expert, George J. Alangaden, M.D., as he discusses how Henry Ford Health System (HFHS) implemented T2MR and the T2Candida Panel as part of their sepsis protocol for the management of candidemia. Dr. Alangaden will also share the positive impact T2MR and T2Candida has had at HFHS on patient length of stay and antifungal use.  

    Learning Objectives:

    • Understand the process for implementation of T2MR and the T2Candida Panel at the Henry Ford Health System (HFHS)
    • Understand the impact of T2Candida Panel on the management of patients with candidemia at HFHS

    Show Resources
    You May Also Like
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    Loading Comments...
    Show Resources